Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_4
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

completed267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)

NCT01674803
unknownnot_applicable

DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity

NCT02175706
completedphase_4

Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent

NCT01826552

Clinical Trials (3)

Showing 3 of 3 trials
NCT01674803Not Applicable

Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)

Completed
NCT02175706Not Applicable

DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity

Unknown
NCT01826552Phase 4

Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3